Company · Roissy Cdg Cedex, Val-D'Oise, France
Guerbet
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 5
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 11
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| DOTAREM | 02459329 | Marketed | |
| LIPIODOL ULTRA FLUID | 00386685 | Marketed | |
| PATENT BLUE SODIUM INJECTION | 00405396 | Marketed | |
| HEXABRIX 200 | 00788805 | Cancelled Post Market | |
| HEXABRIX 320 | 00603740 | Cancelled Post Market |
Notices of Compliance
Newest first.
- LIPIODOL ULTRA FLUIDMarch 12, 2026 · NOC 37090 · Supplement to a New Drug Submission (SNDS)
- DOTAREMOctober 20, 2025 · NOC 36212 · Supplement to a New Drug Submission (SNDS)
- DOTAREMJuly 6, 2023 · NOC 31132 · Supplement to a New Drug Submission (SNDS)
- DOTAREMDecember 11, 2019 · NOC 23000 · Supplement to a New Drug Submission (SNDS)
- DOTAREMApril 24, 2018 · NOC 20784 · Supplement to a New Drug Submission (SNDS)
- DOTAREMMarch 23, 2018 · NOC 20658 · Supplement to a New Drug Submission (SNDS)
- LIPIODOL ULTRA FLUIDJuly 13, 2017 · NOC 19537 · New Drug Submission (NDS)
- DOTAREMJune 19, 2017 · NOC 19440 · Supplement to a New Drug Submission (SNDS)
- DOTAREMNovember 25, 2016 · NOC 18694 · New Drug Submission (NDS)
- HEXABRIX 200; HEXABRIX 320May 6, 2013 · NOC 14339 · New Drug Submission (NDS)
- OXILANJanuary 31, 2005 · NOC 6229 · New Drug Submission (NDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Dotarem Injection: Product SterilityNovember 22, 2021 · Drugs · Product safety · Type I